Algert Global’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-33,430
| Closed | -$37K | – | 1355 |
|
|
2022
Q4 | $37K | Hold |
33,430
| – | – | ﹤0.01% | 1106 |
|
|
2022
Q3 | $78K | Hold |
33,430
| – | – | ﹤0.01% | 1120 |
|
|
2022
Q2 | $101K | Buy |
+33,430
| New | +$101K | 0.01% | 1114 |
|
|
2021
Q4 | – | Sell |
-10,200
| Closed | -$76K | – | 1157 |
|
|
2021
Q3 | $76K | Buy |
+10,200
| New | +$76K | 0.01% | 986 |
|
|
2020
Q3 | – | Sell |
-27,090
| Closed | -$187K | – | 507 |
|
|
2020
Q2 | $187K | Sell |
27,090
-13,320
| -33% | -$91.9K | 0.06% | 335 |
|
|
2020
Q1 | $192K | Buy |
40,410
+15,100
| +60% | +$71.7K | 0.08% | 305 |
|
|
2019
Q4 | $221K | Hold |
25,310
| – | – | 0.07% | 303 |
|
|
2019
Q3 | $84K | Sell |
25,310
-4,050
| -14% | -$13.4K | 0.03% | 334 |
|
|
2019
Q2 | $145K | Buy |
29,360
+15,178
| +107% | +$75K | 0.05% | 303 |
|
|
2019
Q1 | $88K | Buy |
+14,182
| New | +$88K | 0.05% | 281 |
|